| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $26.77B | $27.25B | $27.94B |
| YoY Revenue Growth % | -1.7% | -2.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.65B | -$1.66B | $4.30B |
| Operating Margin % | 13.6% | -6.1% | 15.4% |
| Net Income (GAAP) | $3.10B | -$1.40B | $3.64B |
| EBITDA (Normalized) | $4.62B | -$675.7M | $5.30B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.31B | $3.27B | $6.24B |
| Capital Expenditures (CapEx) | $1.20B | $1.23B | $1.26B |
| Free Cash Flow (FCF) | $2.11B | $2.05B | $4.99B |
| FCF Margin % | 7.9% | 7.5% | 17.8% |
| Return on Invested Capital (ROIC %) | 3.7% | -1.7% | 16.8% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $54.04B | $53.45B | $7.84B |
| Total Stockholders' Equity | $41.14B | $42.52B | $16.09B |